Health care workers first.
Then teachers?
Then older people who are most at risk. That’s where my dad, Charles and I might get to have it.
I’m not keen on getting it before March or April. I want the new FDA management and outside scientists to review the longer-term data first. And me. But if it’s reasonably safe and effective, I’m in.
I’m a bit wary of the mRNA vaccines, because it has never been used as a vaccine before. But more about efficacy that danger, and the early data looks very good.
I’m tired of being locked down, but not enough to risk getting out and about without a vaccine.
Then teachers?
Then older people who are most at risk. That’s where my dad, Charles and I might get to have it.
I’m not keen on getting it before March or April. I want the new FDA management and outside scientists to review the longer-term data first. And me. But if it’s reasonably safe and effective, I’m in.
I’m a bit wary of the mRNA vaccines, because it has never been used as a vaccine before. But more about efficacy that danger, and the early data looks very good.
I’m tired of being locked down, but not enough to risk getting out and about without a vaccine.